Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ras suppressor protein 1 pseudogene 2 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||||
|
papillary thyroid carcinoma susceptibility candidate 1 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||||
|
FAM24B-CUZD1 readthrough |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||||
|
endogenous retrovirus group S71 member 2 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||||
|
microRNA 219b |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||||
|
JADE1 adjacent regulatory RNA |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||||
|
GALNT8 antisense upstream 1 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||||
|
CD2 cytoplasmic tail binding protein 2 | 1.5E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||||
|
dehydrogenase/reductase 1 | 4.0E-15 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||||
|
lipocalin 8 | 8.8E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||||
|
exocyst complex component 8 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||||
|
WAP four-disulfide core domain 5 | 3.4E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||||
|
R3H domain and coiled-coil containing 1 | 1.4E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||||
|
fragile site, aphidicolin type, common, fra(6)(p22.2) |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||||
|
fragile site, aphidicolin type, common, fra(10)(q26.1) |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||||
|
SERTA domain containing 3 | 1.8E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||||
|
complement C1q like 4 | 0.42 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||||
|
placenta expressed transcript 1 | 6.9E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||||
|
lipase B, lysosomal acid type |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||||
|
GTF2I repeat domain containing 2 pseudogene 1 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||||
|
GPR107 adjacent cis regulating lncRNA |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||||
|
UTP18 small subunit processome component | 2.3E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||||
|
ybeY metalloendoribonuclease | 1.3E-07 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2005 | 2005 | ||||||||||
|
DEAD-box helicase 28 | 1.3E-08 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||||
|
Rh family B glycoprotein (gene/pseudogene) | 1.1E-13 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 |